BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Antoniou E, Margonis GA, Sasaki K, Andreatos N, Polychronidis G, Pawlik TM, Pikoulis E. Is resection of pancreatic adenocarcinoma with synchronous hepatic metastasis justified? A review of current literature: Pancreatic adenocarcinoma and liver metastases. ANZ Journal of Surgery 2016;86:973-7. [DOI: 10.1111/ans.13738] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Kaiser J, Hinz U, Mayer P, Hank T, Niesen W, Hackert T, Gaida MM, Büchler MW, Strobel O. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma. Eur J Surg Oncol 2021;47:1734-41. [PMID: 33622577 DOI: 10.1016/j.ejso.2021.02.011] [Reference Citation Analysis]
2 Yu X, Gu J, Fu D, Jin C. Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis. International Journal of Surgery 2017;48:149-54. [DOI: 10.1016/j.ijsu.2017.10.066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
3 Srinivasa S, Koea JB. Thinking the unthinkable. ANZ J Surg 2016;86:959-60. [PMID: 27910269 DOI: 10.1111/ans.13802] [Reference Citation Analysis]
4 Zhou W, Wang D, Lou W. Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis. Cancer Control 2020;27:1073274820976593. [PMID: 33238715 DOI: 10.1177/1073274820976593] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wei M, Shi S, Hua J, Xu J, Yu X; Chinese Study Group for Pancreatic Cancer (CSPAC). Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1). BMJ Open 2019;9:e033452. [PMID: 31818843 DOI: 10.1136/bmjopen-2019-033452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Filippini DM, Grassi E, Palloni A, Carloni R, Casadei R, Ricci C, Serra C, Ercolani G, Brandi G, Di Marco M. Searching for novel multimodal treatments in oligometastatic pancreatic cancer. BMC Cancer 2020;20:271. [PMID: 32228504 DOI: 10.1186/s12885-020-06718-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Klein F, Pelzer U, Schmuck RB, Malinka T, Felsenstein M, Denecke T, Pratschke J, Bahra M. Strengths, Weaknesses, Opportunities, and Threats of Centralized Pancreatic Surgery: a Single-Center Analysis of 3000 Consecutive Pancreatic Resections. J Gastrointest Surg 2019;23:492-502. [PMID: 30187320 DOI: 10.1007/s11605-018-3867-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]